Table 2. Health care utilization outcomes.
Top: mean (standard deviation); bottom: median (IQR). PDiff, p-value testing difference between control and monitoring group; PEquiv, p-value testing equivalence between groups; *, Median and IQR all zero.
Baseline | Follow-up | Mean Difference | PDiff | PEquiv | ||||
---|---|---|---|---|---|---|---|---|
Control N = 85 | Monitoring N = 75 | Control N = 65 | Monitoring N = 65 | Control N = 65 | Monitoring N = 65 | |||
Total Claims ($) | 4,265 (10,190) | 7,159 (25,251) | 5,596 (22,187) | 6,026 (21,426) | 1,331 (21,042) | −1,133 (31,465) | 0.62 | 0.027 |
961 (3,166) | 990 (2,340) | 807 (2,734) | 845 (2,273) | 0 (2,372) | 0 (1,780) | |||
Condition Claims ($) | 1,512 (6,868) | 2,434 (14,296) | 6,165 (37,153) | 630 (21,43) | 4,653 (35,795) | −1,805 (14,406) | 0.50 | 0.105 |
163 (375) | 117 (387) | 111 (379) | 179 (516) | 0 (208) | 0 (283) | |||
Pharmacy Claims ($) | 1,519 (2,687) | 1,859 (5,315) | 1,667 (2,780) | 2,188 (6,340) | 147 (1,057) | 329 (1,860) | 0.60 | 0.037 |
325 (1,590) | 345 (1,164) | 611 (1,603) | 340 (1,458) | 11 (531) | 0 (321) | |||
Total Visits (#) | 4.49 (5.01) | 4.92 (6.51) | 4.17 (4.21) | 4.77 (5.35) | −0.32 (3.75) | −0.15 (6.35) | 0.57 | 0.014 |
3 (6) | 3 (4) | 2 (7) | 3 (5) | 0 (2) | 0 (3) | |||
Office Visits (#) | 4.11 (4.41) | 4.05 (4.09) | 3.95 (3.92) | 4.32 (4.48) | −0.15 (3.30) | 0.28 (3.60) | 0.46 | 0.038 |
3 (5) | 3 (4) | 2 (5) | 3 (4) | 0 (2) | 0 (2) | |||
ER Visits (#)* | 0.17 (0.60) | 0.03 (0.17) | 0.05 (0.37) | 0.06 (0.30) | −0.12 (0.72) | 0.03 (0.35) | 0.06 | 0.137 |
Inpatient Stays (#)* | 0.22 (0.94) | 0.85 (4.27) | 0.17 (0.89) | 0.38 (1.88) | −0.05 (1.16) | −0.46 (4.30) | 0.82 | 0.042 |